Navigation Links
Anti-retroviral drug conserving trial halted

The National Institute of Health has asked to stop SMART trial (Strategies for Management of Anti-retroviral Therapy) which is a trial on AIDS patients who are undergoing Anti-retroviral //therapy which recommends patients to have the drugs only when it is required contrasting to routine therapy which requires daily intake of these drugs.

The drug-conserving trial which is aimed at reducing the side effects of the drug and also helps economically by reducing the amount of money spent on AIDS drugs. The drug is recommended only when the CD4+ counts of the immune system of the patients gets reduced.

The SMART study had more than 5,000 study recruits from 33 countries and the NIH funded the drug conserving trial which it found would help the patients but NIH found that the patients who took off from the drug got more sicker than the patients who took anti-retroviral drugs daily. The results of the study made NIH to ask its collaborators to stop the trial immediately and as asked the patients to continue with daily medications.


'"/>




Page: 1

Related medicine news :

1. CMSI produces Low cost Anti-retroviral drugs in India
2. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
3. One Lakh HIV Patients to get Free Anti-retroviral Drugs by 2007
4. Mental Illness Reversed with Anti-retrovirals in HIV Cases
5. Man against HIV – new vaccine ready for human trials
6. Male contraceptive in trial
7. How do patients benefit of clinical trials
8. Glenmark’s new molecule to go through trial
9. Clinical trials need to be more frank
10. First head-to-head trials of once weekly Fosamax and Actonel therapies
11. Hormone Replacement Therapy increases the risk of endometrial cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece ... “Mary Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda ... women who had little knowledge of the female characters portrayed in the Holy Bible. ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Christmas in Suffolk”: ... of published author, Sara Seymour, who lives in Lafayette, Indiana where she works in ... on iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new ...
(Date:1/19/2017)... ... January 20, 2017 , ... Today, the Centers for Medicare ... four of CMS’s Alternative Payment Models (APMs) in 2017. Clinicians who participate in APMs ... are an important part of the Administration’s effort to build a system that delivers ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and Clinical ... of their drug rehab center in Delray Beach, Florida has been changed from Sober ... stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin overdoses, ...
(Date:1/19/2017)... ... 19, 2017 , ... WholeHealth is announcing their participation in ... Andrew Petersen and Trish Henrie-Barrus will be present Saturday and Sunday in the ... , “We know it’s easy to get carried away when you’re having ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Report Details ... Alzheimer,s Disease Therapeutics and ... our new study reveals trends, R&D progress, and predicted ... the Alzheimer,s disease therapeutics and diagnostics market. Our new ... - How is the Alzheimer,s disease therapeutics and diagnostics ...
(Date:1/19/2017)... BOSTON , Jan. 19, 2017  Stealth BioTherapeutics ... therapeutics to treat mitochondrial dysfunction, today announced new additions ... , M.D., as Chief Medical Officer, and Daniel ... Stealth announced that Jim Carr , Pharm.D. has ... "We are pleased to welcome Doug and Daniel ...
(Date:1/19/2017)... 19, 2017 Accuray Incorporated (Nasdaq: ... Systems continue to set the bar for excellence in ... overall user satisfaction rating among radiation treatment delivery systems ... Buyline Market Intelligence Briefing™. The most recent ratings trend ... among industry peers for 11 of the past 12 ...
Breaking Medicine Technology: